4//SEC Filing
Pons Jaume 4
Accession 0001415889-24-011128
CIK 0001810182other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 4:49 PM ET
Size
9.0 KB
Accession
0001415889-24-011128
Insider Transaction Report
Form 4
Pons Jaume
PRESIDENT & CSO
Transactions
- Exercise/Conversion
Common Stock
2024-04-16$0.99/sh+25,846$25,588→ 654,205 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-04-16−25,846→ 204,433 totalExercise: $0.99Exp: 2027-03-30→ Common Stock (25,846 underlying) - Sale
Common Stock
2024-04-16$14.20/sh−50,000$710,195→ 604,205 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.47, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The shares subject to the option are fully vested and immediately exercisable.
Documents
Issuer
ALX ONCOLOGY HOLDINGS INC
CIK 0001810182
Entity typeother
Related Parties
1- filerCIK 0001816977
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 4:49 PM ET
- Size
- 9.0 KB